KFDA agonizes over extended duration of new drug approvals

The Korea Food and Drug Administration has worried the extended period of screening the approval of new drugs due to shortage of manpower, as all of drug license business was incorporated into the National Toxicity Research Institute during the latter half of last year and furthermore, the review function on screening of safety and efficacy for drugs, etc. was again transferred to the Safety Ev...